References
- Brion P. H., Mittal‐Henkle A., Kalunian K. C. Autoimmune skin rashes associated with etanercept for rheumatoid arthritis. Ann Intern Med 1999; 131: 634
- Vergara G., Silvestre J. F., Betlloch I., Vela P., Albares M. P., Pascual J. C. Cutaneous drug eruption to infliximab: report of 4 cases with an interface dermatitis pattern. Arch Dermatol 2002; 138: 1258–9
- Beuthien W., Mellinghoff H. U., von Kempis J. Skin reaction to adalimumab. Arthritis Rheum 2004; 50: 1690–2
- Dereure O., Guillot B., Jorgensen C., Cohen J. D., Combes B., Guilhou J. J. Psoriatic lesions induced by antitumour necrosis factor treatment: two cases. Br J Dermatol 2004; 150: 506–7
- Haibel H., Spiller I., Strasser C. Unexpected new onset or exacerbating of psoriasis in treatment of active ankylosing spondylitis with TNF blocking agents. Ann Rheum Dis 2004; 63((Suppl))405
- Grinblat B., Scheinberg M. Unexpected onset of psoriasis during infliximab treatment: comment on the article by Beuthien et al. Arthritis Rheum 2005; 52: 1333–42
- Sfikakis P. P., Iliopoulos A., Elezoglou A., Kittas C., Stratigos A. Psoriasis induced by anti‐tumor necrosis factor therapy. Arthritis Rheum 2005; 52: 2513–18
- Flendrie M, Vissers W, Creemers M, de Jong E, van de Kerkhof P, van Riel P. 2005. Dermatological condition during TNF‐alpha blocking therapy in patients with rheumatoid arthritis: a prospective study. Arthritis Res Ther. 7. R666-76
- Kary S., Worm M., Audring H., Huscher D., Renelt M., Sorensen H., et al. New onset or exacerbation of psoriatic skin lesions in patients with definitive rheumatoid arthritis receiving tumour necrosis factor antagonists. Ann Rheum Dis 2006; 65: 405–7
- Adams D. R., Buckel T., Sceppa J. A. Infliximab associated new‐onset psoriasis. J Drugs Dermatol 2006; 5: 178–9